Screener
Alnylam Pharmaceuticals ALNY Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $40.19B.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's market capitalization?
- Alnylam Pharmaceuticals (ALNY) reported market capitalization of $40.19B in Q2 2026.
- How has Alnylam Pharmaceuticals's market capitalization changed year-over-year?
- Alnylam Pharmaceuticals's market capitalization decreased by 5.2% year-over-year, from $42.38B to $40.19B.
- What is the long-term trend for Alnylam Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's market capitalization has grown at a 27.6% compound annual growth rate (CAGR), from $15.54B to $52.54B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Alnylam Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude